First in class dual MDM2/MDMX inhibitor ALRN-6924 enhances antitumor efficacy of chemotherapy in TP53 wild-type hormone receptor-positive breast cancer models
首创双重 MDM2/MDMX 抑制剂 ALRN-6924 可增强 TP53 野生型激素受体阳性乳腺癌模型中化疗的抗肿瘤疗效
期刊:Breast Cancer Research
影响因子:6.1
doi:10.1186/s13058-021-01406-x
Seyed Pairawan, Ming Zhao, Erkan Yuca, Allen Annis, Kurt Evans, David Sutton, Luis Carvajal, Jian-Guo Ren, Solimar Santiago, Vincent Guerlavais, Argun Akcakanat, Coya Tapia, Fei Yang, Priya Subash Chandra Bose, Xiaofeng Zheng, Ecaterina Ileana Dumbrava, Manuel Aivado, Funda Meric-Bernstam